Biotech is big, and the industry has been big for quite some time.
As a matter of fact, biotechnology has been the second-best performing industry over the last two years.
Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.
However, at the end of the day, the big biotechs are the ones that make the headlines.
Related Link: Celgene Sells Off, But Begins Move Back Up
Below is a list of the five biggest biotech stocks by market capitalization.
The biotech stock with the fifth-largest market cap is Regeneron Pharmaceuticals Inc REGN.
At time of writing, Regeneron’s market cap sat just over $41 billion.
The fourth-largest biotech stock is Biogen Idec Inc (NASDAQ: BIIB).
Biogen’s market cap is more than double that of Regeneron at above $83 billion.
Coming in as the third-biggest biotech stock on the block is Celgene Corporation CELG.
Celgene has a market capitalization of $98 billion.
The second-largest biotech stock by market cap is Amgen, Inc. AMGN.
With a market cap of $120 billion, Amgen is still a distance from the largest biotech of them all.
The biggest biotech is Gilead Sciences, Inc. GILD.
Gilead is bigger than both Biogen and Regeneron put together with a market cap of over $155 billion.
All five stocks closed up in the green on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.